News & Events
News, industry insights and noteworthy events.
At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.
For media or press inquiries, please email us.
Contact UsAll Articles
-
Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership with Agenus
Read original publication on Business Wire: click here Charlotte, N.C., and Lexington, Mass. – Tanner Pharma, a global provider of specialty medicine access solutions, today announced a collaboration with Agenus, a leading immuno-oncology company, to provide expanded access to botensilimab (BOT) and balstilimab (BAL). Through a Named Patient Program (NPP), this initiative offers patients with…
Read More -
Tanner Pharma Directors to Attend Key International Healthcare Conferences in 2025
Directors from Tanner Pharma Group will attend several international healthcare conferences in the coming weeks. Connect with our team members directly or via conference platforms to schedule meetings. We look forward to meeting with you. JPM Healthcare Conference 13-16 January | San Francisco, CA USA Arab Health 27-30 January | Dubai SCOPE Summit 3-6 February…
Read More -
Tanner Pharma Group Recognized by the Charlotte Business Journal as One of the Best Places to Work
We are pleased to share that Tanner Pharma Group has been recognized as one of the Best Places to Work by the Charlotte Business Journal. This honor reflects our dedication to our employees and the communities we serve. Here’s a closer look at what we feel makes Tanner Pharma Group a remarkable workplace: Employee Engagement…
Read More -
Tanner Contributes to 4 Organizations Who Are Improving Patient Lives Around the World
At Tanner, we believe every gesture of kindness becomes a ripple of change, and we are honored to contribute to the greater good by donating $20,000 across four organizations who are helping to improve patient lives around the world. This contribution, made through Tanner’s philanthropic arm, TannerCares, was inspired by Tanner EVP Jonathan Bracey’s young…
Read More -
The Chairman’s Award 2024: Rilee Humphries
The Chairman’s Award is Tanner’s highest accolade. It is awarded to the associate who goes above and beyond to meet the needs of our team and our partners, and exemplifies our Tanner values of determined and tenacious, resourceful and creative, and responsive and caring to further enable us to pursue our mission to improve patient…
Read More -
A Rare Affair 2024
The rare disease community is a diverse and resilient group of people who face many challenges in their quest for better health and quality of life. They are not alone in this journey, as they are supported by dedicated and passionate organizations that work tirelessly to develop and deliver innovative therapies for rare genetic diseases. One of these organizations is Ultragenyx, a biopharmaceutical company focused on the development of novel products…
Read More -
Max Global Experience: Cambodia
In a heartwarming journey that embodies our commitment to improving global access to critical medicines, Tanner Pharma Group proudly served as the title sponsor for The Max Foundation’s “Max Global Experience: Cambodia.” This remarkable expedition, attended by our EVP of Managed Access Programs, Rob Keel, not only showcased the unique barriers that people face in…
Read More -
Celebrating Impact: Tanner’s Annual Charity Golf Day
Our Annual Charity Golf Day at Redbourn Golf Club is not just a day on the green; it’s a day of camaraderie and making an impact. This year’s event was truly special, and we’re happy to share a few highlights. Charities Close to Our Hearts This year we were proud to nominate three UK charities:…
Read More -
Tanner Pharma Group Announces Start of Construction for Cutting-Edge US Operations Facility
We are thrilled to share that Tanner Pharma Group is embarking on a new chapter of growth and expansion with the start of construction for a new, state-of-the-art operations facility in Charlotte, NC USA. This milestone signifies our unwavering commitment to enabling patient access and providing enhanced storage, distribution, and logistics capabilities to our partners…
Read More -
Tanner Pharma Group Initiates a Global Innovative Named Patient Program for Zemdri
Charlotte, NC, May 23, 2023 – Tanner Pharma Group and Cipla Therapeutics Inc. have jointly launched an innovative Named Patient Program (NPP) for Zemdri (plazomicin) Injection. The collaboration will expand access to Zemdri on a Named Patient basis in countries and regions where the drug is not yet commercially accessible, for patients 18 years of…
Read More -
ORPHELIA Pharma Selects Tanner Pharma Group to Initiate Named Patient Program for KIMOZO® (temozolomide) in European Countries
PRESS RELEASE Paris (France) and Charlotte, N.C. (USA), on April 18th, 2023 – ORPHELIA Pharma, a French biopharmaceutical company dedicated to the development and marketing of pediatric and orphan medicines, and Tanner Pharma Group, a global provider of integrated specialty access solutions, have signed an exclusive agreement to manage the supply and distribution of Ped-TMZ,…
Read More -
Tanner Pharma Group and ExeGi Pharma Announce Partnership to Distribute High Potency Probiotic in Mexico to Support Patients with Gut Microbiome Imbalance
Rockville, M.D., and Charlotte, N.C., April 12, 2023 – ExeGi Pharma LLC (“ExeGi”), a leading developer of live biotherapeutic drugs and probiotics, has announced a partnership with TannerLAC, Inc. (“TannerLAC”), a division of Tanner Pharma Group, to distribute Visbiome® in Mexico. Visbiome® is a high-potency probiotic medical food that helps manage dysbiosis associated with medical…
Read More -
Tanner Pharma Group to Distribute an Innovative Product that Protects and Repairs the Gastrointestinal Mucosa
Teramo (Italy) and Charlotte, N.C. (USA), on April 3, 2023 – Azienda Farmaceutica Italiana (“AFI”), an Italian pharmaceutical company and innovator in therapeutic solutions and new treatment possibilities, and TannerLAC, Inc. (“TannerLAC”), a division of Tanner Pharma Group, have entered into a license agreement for the distribution of Hepilor® in Latin America. Hepilor® is a…
Read More -
International Women’s Day 2023
International Women’s Day (March 8) is a global day dedicated to celebrating the achievements of women and raising awareness about women’s equality. Learn more about what International Women’s Day means to some of our Tanner team members. What Does International Women’s Day Mean to You? “International Women’s Day is an opportunity to celebrate the givers…
Read More -
The Chairman’s Award 2023: Gaby Bedoya
The Chairman’s Award is Tanner’s highest accolade. It is awarded to the associate who goes above and beyond to meet the needs of our team and our partners, and exemplifies our Tanner values of determined and tenacious, resourceful and creative, and responsive and caring to further enable us to pursue our mission to improve patient…
Read More -
Insights From a Multi-Stakeholder Discussion on Early Access Pathways to Medicine
In partnership with RARE Revolution, Tanner Pharma Group co-hosted a webinar that brought together stakeholders to discuss early access pathways to medicines. Discussion topics covered the role of patient groups and healthcare professionals, communication strategies, real-world data collection, equitable access, ethical issues and patient pathways to access. Medicines that treat a particular rare disease may…
Read More -
TannerCares Hosts Team Volunteer Event with Second Harvest Food Bank of Metrolina
TannerCares is the philanthropic commitment of our company and was built as a means to support the causes of our partners and team members through the giving of time and financial resources. The Tanner Volunteer Program is a component of this initiative and serves as a way to strengthen our local communities and provide our…
Read More -
Managing aggressive timelines for clinical trials on a global scale
Sourcing clinical trial products and distributing them in accordance with strict timelines and country-specific regulations can make or break a trial’s success. And with more clinical trials taking place across several countries and within hard-to-reach regions, managing these requirements presents a range of complications for trial sponsors. In this article, we provide insights on clinical…
Read More